Treating NSCLC with tyrosine kinase / EGFR inhibitors erlotinib & gefitinib (Review) - PulmCCM
Advertisement
Mar 042011
 

Treating NSCLC with tyrosine kinase / EGFR inhibitors erlotinib & gefitinib: Cataldo VD, NEJM 2011;364:947-955. Non small cell lung cancer chemotherapy treatment review.

Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.

Leave a Reply